Acer Medical Inc. (TPEX:6857)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
90.00
0.00 (-1.64%)
Sep 4, 2026, 12:58 PM CST

Acer Medical Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-23.69-29.69-27.36-38.18-54.71-20.45
Depreciation & Amortization
0.630.580.570.720.480.06
Other Amortization
0.730.660.660.590.190.02
Loss (Gain) From Sale of Assets
-0.04-0.08-0--
Asset Writedown & Restructuring Costs
-----0
Stock-Based Compensation
0.020.020.03-0.02-
Other Operating Activities
-0.5-0.73-2.95-0.53-0.06-
Change in Accounts Receivable
-4.61-2.986.17-4.5-0.47-4.09
Change in Inventory
-0.41-1.510.91-12.130.76-0.76
Change in Accounts Payable
-1.360.74-11.267.560.060.12
Change in Unearned Revenue
1.331.40.230.01-1.021.02
Change in Other Net Operating Assets
3.926.932.31-6.688.975.27
Operating Cash Flow
-23.96-24.65-20.7-53.13-45.77-18.82
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.39-1.08---3.2-0.51
Sale of Property, Plant & Equipment
0.160.47-0.010.04-
Cash Acquisitions
--3.61---
Sale (Purchase) of Intangibles
-2.32---0.76-4.21-0.36
Investment in Securities
--2.5--2.580-80
Other Investing Activities
-0.99-1.37-0.16-0.15--
Investing Cash Flow
-4.54-4.483.45-3.472.63-80.87

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-2.5----
Total Debt Issued
2.52.5----
Net Debt Issued (Repaid)
-2.5----
Issuance of Common Stock
----200.01106
Financing Cash Flow
-2.5--200.01106

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-28.5-26.63-17.25-56.53226.886.32

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-25.35-25.73-20.7-53.13-48.97-19.32
Free Cash Flow Growth
------
Free Cash Flow Margin
-35.97%-42.84%-41.27%-193.57%-374.94%-200.71%
Free Cash Flow Per Share
-1.67-1.69-1.36-3.49-3.97-2.49
Levered Free Cash Flow
-20.58-16.43-11.08-41.44-32.95-12.07
Unlevered Free Cash Flow
-20.57-16.42-11.08-41.44-32.95-12.07
Free Cash Flow After Leases
-25.35-25.73-20.7-53.13-48.97-19.32

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.020.01----
Cash Income Tax Paid
0.370.050.340.230.01-
Change in Working Capital
-1.114.598.35-15.738.31.55